Hanmi Science Co., Ltd. (KRX:008930)

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Holding Company Division	76.35B	64.06B	66.30B	39.04B	36.33B
Other Categories	19.44B	19.13B	15.54B	4.52B	2.10B
Healthcare Business Division	155.11B	129.47B	120.12B	18.45B	-
Pharmaceutical Wholesale Division	1.14T	1.10T	1.07T	990.06B	916.53B
Unallocated Adjustment and Removal	-30.62B	-29.56B	-25.27B	-6.02B	-4.79B
Total	1.36T	1.28T	1.25T	1.05T	950.16B

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
South Korea	1.32T	1.25T	1.21T	1.04T	944.34B
China	33.84B	33.38B	33.86B	8.74B	5.82B
Other	1.02B	1.92B	2.23B	317.79M	3.12M
Total	1.36T	1.28T	1.25T	1.05T	950.16B

Data Source: S&P Global Market Intelligence Last updated: Aug 14, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 28, 2026

Data Sources Report a data error